Patient views on colorectal cancer screening methods
Part of Cancer, Digestive system clinical trials.
This study asks people aged 50–69 about their experience and preferences with different screening methods for colorectal cancer. It aims to improve screening programs by understanding what patients prefer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 69 years old.
- You have been invited to take part in a population-based colorectal cancer screening program.
- You are able to provide a stool sample for the fecal occult blood test (FOBT) at your primary care center.
- You must be willing to sign a consent form after understanding what the study involves.
- You should not have already had a colonoscopy because of a positive FOBT result before signing the consent form.
- You should not be a dependent or have a close personal or work relationship with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
This study collects data to improve how colorectal cancer is found and diagnosed. It compares new testing methods (like breath and stool tests) with standard colonoscopy in people with and without cancer or risk factors.
This study follows people age 40 and older to see how well colorectal cancer screening works in everyday community care. You may answer risk and follow-up questions over time, and the study looks for any cancer diagnoses that happen outside the study hospitals.
This study looks at patterns of colorectal (colon and rectum) findings in people who are having a colonoscopy as part of routine care. It may help improve how doctors detect and understand colorectal cancer and related growths over time.
This study follows patients with colorectal cancer over time to understand the disease better. It does not test a new treatment, but collects information from medical records and visits.
This study tests whether training doctors to better involve patients in decisions about colorectal cancer screening improves shared decision-making. If you are between 50 and 74 and due for screening, your GP might invite you to join.
Hear when a new Survey and Questionnaire trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.